Aquestive Therapeutics, Inc. (AQST)
3.31
-0.03
(-0.90%)
USD |
NASDAQ |
Jan 16, 16:00
3.27
-0.04
(-1.21%)
Pre-Market: 08:12
Aquestive Therapeutics Total Liabilities (Quarterly): 167.67M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Insmed, Inc. | 1.415B |
| Merck & Co., Inc. | 77.64B |
| Beta Bionics, Inc. | 35.29M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
| Palatin Technologies, Inc. | 8.218M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 163.56M |
| Shareholders Equity (Quarterly) | -4.109M |
| Debt to Equity Ratio | -31.36 |
| Current Ratio | 5.931 |
| Net Debt Paydown Yield | -0.35% |